Locking Down Shape-Shifting Spike Protein Aids Development of COVID-19 Vaccine

August 5, 2020 • by Marc Airhart
A man receives a shot in the arm from a doctor wearing a mask, face sheild and gloves

An engineered protein developed by UT Austin researchers and their colleagues is a key element of COVID-19 vaccines currently in human trials by Moderna, Novavax, Pfizer-BioNTech and Johnson & Johnson.


Share